The American Academy of Allergy, Asthma and Immunologyl has reaffirmed its doubts about the scientific status of what is known as multiple chemical sensitivity (MCS). Yet despite a long line of such authoritative rejections2-4 MCS continues to gain in popularity, political support and media attention. The emergence of MCS followed reports of a multitude of symptoms triggered by exposure to substances in the environment5-9. These substances include synthetic fabrics, food additives, paints and pesticides. Other labels for multiple chemical sensitivity are listed in Box 1.
The characteristic feature of multiple chemical sensitivity is that the reported symptoms are unaccompanied by physical signs or biomedical test abnormalitiesl1. Nevertheless the symptoms (Box 2) are usually attributed to immunological or neurological dysfunction caused by environmental toxins.
The status of this illness is viewed with scepticism by many physicians11 12 Investigators who highlighted the association of depression and anxiety disorders with MCS came under angry attack, including calls for this sort of research to be stopped14-an illustration of the continuing stigmatization of psychological disorders as well as the persistence of mind-body dualism. Mayou et al.33 have emphasized the limitations of current classification systems, and propose that a multidimensional system taking account of the patient's illness beliefs, behaviour, physiological disturbance and mental state would be more helpful.
MANAGEMENT
The mainstay of treatment provided by clinical ecologists is the avoidance of offending chemicals. This has led to the development of 'safe-rooms' and even 'ecology houses' residential units that are free of plastics and other synthetic materials, with filtering systems to cleanse incoming air. Provocation-neutralization is a method of assessment and treatment advocated by clinical ecologists3. This entails progressively higher doses of a supposed environmental trigger (sublingually or intradermally) until the patient complains of symptoms. Then a 'neutralizing' dose is identified at which symptoms are eliminated, and the patient is advised that the treatment may have to be repeated. Although there are many anecdotal reports on these treatments, controlled studies are notably lacking3 '12. Nor are they without hazards: first, they can result in extreme social and nutritional deprivation; secondly, there is the missed opportunity for effective treatment. In the absence of evidence-based specific treatments for MCS, a pragmatic approach34 would involve a broad assessment of the patient with appropriate investigation, treatment of any psychiatric disorder and guidance that promotes physical and social functioning rather than withdrawal into a life of worsening disability. Clinicians must acknowledge the reality of patients' complaints if a constructive relationship is to be maintained; and patients will often willingly discuss the emotional factors in their illness if they feel their symptoms are being taken seriously. The extent to which medically unexplained symptoms should be investigated requires careful thought since a continued pursuit of unproductive tests will reinforce the patient's belief that organic disease is present. 
